A Look At Healthcare Realty Trust’s Valuation As Earnings Beat And Insider Buying Lift Optimism

Insider buying, earnings surprise and auditor change put Healthcare Realty Trust in focus

Healthcare Realty Trust (HR) has drawn fresh attention after a Q4 2025 earnings beat coincided with insider share purchases by senior leaders and an auditor switch to Deloitte & Touche LLP.

See our latest analysis for Healthcare Realty Trust.

The share price has started to reflect this improving narrative, with an 8.9% 1 month share price return and 7.7% 3 month share price return helping lift the 1 year total shareholder return to 17.3%, although the 5 year total shareholder return is still a 20.0% decline.

If this mix of insider buying and earnings beats has you thinking about what else might be setting up for a rerating, you could take a look at 19 top founder-led companies as a starting point for new ideas.

With the shares up strongly over the past year but still trading at a discount to one analyst price target and to some estimates of intrinsic value, it is worth asking whether there is still a buying opportunity here or whether the market is already pricing in future growth.

Most Popular Narrative: 5% Undervalued

With Healthcare Realty Trust last closing at $18.43 against a most-followed fair value of $19.40, the current setup leans toward a modest valuation gap that hinges on execution and capital deployment.

Embedded value add opportunity in the lease up portfolio (targeting ~$50 million incremental NOI from increasing occupancy/rental rates through $300 million of internally funded capital projects) provides a clear path to outsized NOI and earnings expansion relative to current suppressed valuation.

Read the complete narrative.

Want to see what is sitting behind that NOI uplift and fair value? Revenue trends, margin rebuild and future P/E expectations are all wired into this narrative.

Result: Fair Value of $19.40 (UNDERVALUED)

Have a read of the narrative in full and understand what’s behind the forecasts.

However, there are still meaningful risks here, including high leverage and potential execution missteps on lease up and capital projects that could blunt the NOI story.

Find out about the key risks to this Healthcare Realty Trust narrative.

Another angle on value: sales ratio sends a mixed signal

Our DCF work suggests Healthcare Realty Trust is trading at a steep discount to fair value. However, its P/S ratio of 5.4x is higher than the North American Health Care REITs average of 4.9x and only slightly below a 5.2x fair ratio, which points to less room for error. Which signal do you trust more?

See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

Curious whether the mix of concerns and optimism in this story lines up with your own view? Act while the information is fresh, and weigh up 1 key reward and 2 important warning signs before you decide where you stand.

Looking for more investment ideas?

If this story has sharpened your thinking, do not stop here. Broaden your watchlist with a few targeted idea lists built from our screeners.

This article by Simply Wall St is general in nature. We provide commentary based on historical data
and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your
financial situation. We aim to bring you long-term focused analysis driven by fundamental data.
Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com